Nonrandomised controlled trial in recurrent glioblastoma patients: the promise of autologous tumour lysate-loaded dendritic cell vaccination

被引：7
|
作者：
Pasqualetti, Francesco [1 ,2 ]
Zanotti, Sofia [3 ]
机构：
[1] Univ Oxford, Dept Oncol, Oxford OX3 7DQ, England
[2] Azienda Osped Univ Pisana, Radiat Oncol, Pisa, Italy
[3] IRCCS Humanitas Univ Res Hosp, Anat Pathol Unit, Milan, Italy
来源：
BRITISH JOURNAL OF CANCER | 2023年 / 129卷 / 06期
关键词：
D O I：
10.1038/s41416-023-02194-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Recently, Liau et al. reported the results of Phase 3 clinical trial testing DCVax-L vaccines on patients with glioblastoma. Despite the promising and significant results obtained, the study design and the long-lasting period of recruitment of this work deserve some reflection.
引用
收藏
页码：895 / 896
页数：2
相关论文
共 50 条
  • [1] Nonrandomised controlled trial in recurrent glioblastoma patients: the promise of autologous tumour lysate-loaded dendritic cell vaccination
    Francesco Pasqualetti
    Sofia Zanotti
    British Journal of Cancer, 2023, 129 : 895 - 896
  • [2] Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
    Shah, Siddharth
    Nag, Aiswarya
    Lucke-Wold, Brandon
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024,
  • [3] Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma: What happened to the evidence?
    Olivier, T.
    Migliorini, D.
    REVUE NEUROLOGIQUE, 2023, 179 (05) : 502 - 505
  • [4] AUTOLOGOUS TUMOR LYSATE-LOADED DENDRITIC CELL VACCINATION IMPROVES SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA: SURVIVAL RESULTS FROM A PHASE 3 TRIAL
    Liau, Linda M.
    Ashkan, Keyoumars
    Brem, Steven
    Campian, Jian
    Trusheim, John
    Iwamoto, Fabio
    Tran, David
    Anstass, George
    Cobbs, Charles
    Heth, Jason
    Salacz, Michael
    D'Andre, Stacy
    Aiken, Robert
    Moshel, Yaron
    Nam, JooYeon
    Pillainayagam, Clement
    Wagner, Stephanie
    Walter, Kevin
    Chaudary, Rekha
    Goldlust, Samuel
    Lee, Ian
    Bota, Daniela
    Elinzano, Heinrich
    Grewal, Jai
    Lillehei, Kevin
    Mikkelsen, Tom
    Walbert, Tobias
    Abram, Steve
    Brenner, Andrew
    Ewend, Matthew
    Khagi, Simon
    Lovick, Darren
    Portnow, Jana
    Kim, Lyndon
    Loudon, William
    Martinez, Nina
    Thompson, Reid
    Avigan, David
    Fink, Karen
    Geoffroy, Francois
    Giglio, Pierre
    Gligich, Oleg
    Krex, Dietmar
    Lindhorst, Scott M.
    Lutzky, Jose
    Meisel, Hans-Joerg
    Nadji-Ohl, Minou
    Sanchin, Lhagva
    Sloan, Andrew
    Bosch, Marnix
    NEURO-ONCOLOGY, 2022, 24 : 66 - 66
  • [5] Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma A Phase 3 Prospective Externally Controlled Cohort Trial
    Liau, Linda M.
    Ashkan, Keyoumars
    Brem, Steven
    Campian, Jian L.
    Trusheim, John E.
    Iwamoto, Fabio M.
    Tran, David D.
    Ansstas, George
    Cobbs, Charles S.
    Heth, Jason A.
    Salacz, Michael E.
    D'Andre, Stacy
    Aiken, Robert D.
    Moshel, Yaron A.
    Nam, Joo Y.
    Pillainayagam, Clement P.
    Wagner, Stephanie A.
    Walter, Kevin A.
    Chaudary, Rekha
    Goldlust, Samuel A.
    Lee, Ian Y.
    Bota, Daniela A.
    Elinzano, Heinrich
    Grewal, Jai
    Lillehei, Kevin
    Mikkelsen, Tom
    Walbert, Tobias
    Abram, Steven
    Brenner, Andrew J.
    Ewend, Matthew G.
    Khagi, Simon
    Lovick, Darren S.
    Portnow, Jana
    Kim, Lyndon
    Loudon, William G.
    Martinez, Nina L.
    Thompson, Reid C.
    Avigan, David E.
    Fink, Karen L.
    Geoffroy, Francois J.
    Giglio, Pierre
    Gligich, Oleg
    Krex, Dietmar
    Lindhorst, Scott M.
    Lutzky, Jose
    Meisel, Hans-Jorg
    Nadji-Ohl, Minou
    Sanchin, Lhagva
    Sloan, Andrew
    Taylor, Lynne P.
    JAMA ONCOLOGY, 2023, 9 (01) : 112 - 121
  • [6] Autologous tumor lysate-loaded dendritic cell vaccination (DCVax-L) in glioblastoma: Breakthrough or fata morgana?
    Preusser, Matthias
    van den Bent, Martin J.
    NEURO-ONCOLOGY, 2023, 25 (04) : 631 - 634
  • [7] Prolonging the Overall Survival by Vaccination of autologous tumor lysate-loaded dendritic Cells (DCVax-L) in Patients with newly diagnosed and recurrent Glioblastoma
    Deng, Maximilian Y.
    Debus, Juergen
    Koenig, Laila
    STRAHLENTHERAPIE UND ONKOLOGIE, 2023, 199 (03) : 327 - 329
  • [8] A pilot study of autologous tumor lysate-loaded dendritic cell vaccination combined with sunitinib for metastatic renal cell carcinoma
    Matsushita, Hirokazu
    Enomoto, Yutaka
    Kume, Haruki
    Nakagawa, Tohru
    Fukuhara, Hiroshi
    Suzuki, Motofumi
    Fujimura, Tetsuya
    Homma, Yukio
    Kakimi, Kazuhiro
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2014, 2
  • [9] The clinical utility of autologous tumor lysate-loaded dendritic cell vaccination for patients with glioma: A systematic review and meta-analysis
    Habibi, Mohammad Amin
    Mirjani, Mohammad Sina
    Ahmadvand, Muhammad Hussain
    Delbari, Pouria
    Arab, Shayan
    Minaee, Poriya
    Eazi, Seyedmohammad
    Ahmadpour, Sajjad
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2024, 20 (06) : 671 - 680
  • [10] COMPARISON OF GLIOMA-ASSOCIATED ANTIGEN PEPTIDE-LOADED VERSUS AUTOLOGOUS TUMOR LYSATE-LOADED DENDRITIC CELL VACCINATION IN MALIGNANT GLIOMA PATIENTS
    Prins, Robert M.
    Everson, Richard
    Soto, Horacio
    Lisiero, Dominique N.
    Young, Emma
    Liau, Linda M.
    NEURO-ONCOLOGY, 2012, 14 : 48 - 49
12345